Pembrolizumab Combined With Cisplatin-based Chemotherapy as First-line Systemic Therapy in Advanced Penile Cancer
Clinical trial NCT04224740 · COMPLETED
Trial details
- NCT number
- NCT04224740
- Sponsor
- Latin American Cooperative Oncology Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-15
- Primary completion
- 2023-11-13
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.